Ftse Mib
35.854,07
-0,57%
DAX
21.303,82
1,25%
S&P 500
6.086,37
0,61%
NASDAQ
20.009,34
1,28%
Bitcoin
102.123,83
-1,46%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ ImmunoPrecise Antibodies Ltd (IPA) ImmunoPrecise Antibodies Ltd (IPA) Notizie

IPA

ImmunoPrecise Antibodies (IPA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IPA
DataOraFonteTitoloSimboloCompagnia
22/01/202520:19Business WireIPA (ImmunoPrecise Antibodies), pionnier des thérapies GLP-1 conçues par l'IA : Un nouveau chapitre potentiel en matière de traitement du diabèteNASDAQ:IPAImmunoPrecise Antibodies Ltd
22/01/202516:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IPAImmunoPrecise Antibodies Ltd
22/01/202513:02Business WireIPA (ImmunoPrecise Antibodies) Pioneers AI-Designed GLP-1 Therapies: A Potential New Chapter in Diabetes TreatmentNASDAQ:IPAImmunoPrecise Antibodies Ltd
18/01/202503:25Business WireImmunoPrecise Antibodies redéfinit sa stratégie de pipeline en faisant appel à l'IA et à l'innovation basée sur les principes premiers pour la découverte de médicamentsNASDAQ:IPAImmunoPrecise Antibodies Ltd
17/01/202514:01Business WireImmunoPrecise Antibodies Realigns Pipeline Strategy, Empowering Drug Discovery with AI and First-Principles InnovationNASDAQ:IPAImmunoPrecise Antibodies Ltd
01/01/202513:44Business WireL'IPA annonce la démission de sa directrice financièreNASDAQ:IPAImmunoPrecise Antibodies Ltd
01/01/202501:56Business WireIPA Announces Resignation of Chief Financial OfficerNASDAQ:IPAImmunoPrecise Antibodies Ltd
23/12/202418:02Business WireImmunoPrecise Antibodies (IPA) démontre une solide confiance du marché avec des achats d'actions par des membres de la directionNASDAQ:IPAImmunoPrecise Antibodies Ltd
23/12/202414:30Business WireImmunoPrecise Antibodies (IPA) Demonstrates Strong Market Confidence with Insider Share PurchasesNASDAQ:IPAImmunoPrecise Antibodies Ltd
19/12/202418:56Business WirePrésentation de l'IPA à la Microcap Conference 2025NASDAQ:IPAImmunoPrecise Antibodies Ltd
19/12/202414:00Business WireIPA to Present at The Microcap Conference 2025NASDAQ:IPAImmunoPrecise Antibodies Ltd
11/12/202412:34Business WireImmunoPrecise Antibodies (IPA) publie ses résultats financiers et les faits saillants de ses activités du deuxième trimestre de l’exercice 2025NASDAQ:IPAImmunoPrecise Antibodies Ltd
10/12/202414:37Edgar (US Regulatory)Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]NASDAQ:IPAImmunoPrecise Antibodies Ltd
10/12/202414:30Business WireImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025NASDAQ:IPAImmunoPrecise Antibodies Ltd
05/12/202412:23Business WireL'IPA participera à la prochaine conférence de découverte en tête-à-tête d'investisseurs organisée par The Benchmark CompanyNASDAQ:IPAImmunoPrecise Antibodies Ltd
04/12/202414:00Business WireIPA to Present at The Benchmark Company’s Upcoming Discovery One-on-One Investor ConferenceNASDAQ:IPAImmunoPrecise Antibodies Ltd
04/12/202405:08Business WireL'IPA publiera ses résultats financiers et les faits importants de son activité récente pour le deuxième trimestre de l'exercice 2025 le 10 décembre 2024NASDAQ:IPAImmunoPrecise Antibodies Ltd
03/12/202414:30Business WireIPA to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025 on December 10, 2024NASDAQ:IPAImmunoPrecise Antibodies Ltd
14/11/202421:13Business WireUne percée commerciale de 20 milliards de dollars : l'IPA est pionnière dans le développement d'anticorps à fort impact pour les thérapies anticancéreuses ADC de nouvelle générationNASDAQ:IPAImmunoPrecise Antibodies Ltd
13/11/202415:00Business Wire$20 Billion Market Breakthrough: IPA Pioneers High-Impact Antibody Development for Next-Generation ADC Cancer TherapiesNASDAQ:IPAImmunoPrecise Antibodies Ltd
05/11/202407:53Business WireImmunoPrecise annonce son TECHDAY, un événement dédié à l'innovation de pointe en matière d'IA et de produits biologiquesNASDAQ:IPAImmunoPrecise Antibodies Ltd
04/11/202414:01Business WireImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics InnovationNASDAQ:IPAImmunoPrecise Antibodies Ltd
29/10/202402:59Business WireImmunoPrecise soutient la recherche antivieillissement dans le cadre d'une étude de la Mayo Clinic et s'apprête à entrer dans un marché de 81 milliards de dollars avec une technologie d'IANASDAQ:IPAImmunoPrecise Antibodies Ltd
28/10/202412:30Business WireImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI TechnologyNASDAQ:IPAImmunoPrecise Antibodies Ltd
23/10/202412:11Business WireImmunoPrecise Antibodies participera à l'AI Driven Drug Discovery Summit USA 2024NASDAQ:IPAImmunoPrecise Antibodies Ltd
21/10/202415:00Business WireImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024NASDAQ:IPAImmunoPrecise Antibodies Ltd
11/10/202401:50Business WireImmunoPrecise Antibodies célèbre le prix Nobel de chimie et les avancées dans la conception de protéines optimisée par l'IANASDAQ:IPAImmunoPrecise Antibodies Ltd
10/10/202414:10Business WireImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein DesignNASDAQ:IPAImmunoPrecise Antibodies Ltd
02/10/202420:06Business WireUne filiale d'ImmunoPrecise signe un accord de transfert de matériel avec BiotheusNASDAQ:IPAImmunoPrecise Antibodies Ltd
02/10/202414:00Business WireImmunoPrecise Subsidiary Signs Material Transfer Agreement with BiotheusNASDAQ:IPAImmunoPrecise Antibodies Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IPA

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
TIT
Telecom Italia
BIT
SPM
Saipem
BIT
PRY
Prysmian
BIT
STLAM
Stellantis NV
BIT
SRG
Snam
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
A2A
A2A
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
CPR
Davide Campari
BIT
STMMI
ST Microelectronics
BIT
BAMI
Banco BPM
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network